About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Texas | 660 Studies

Clinical Trials Pancreatic CancerTexas

Pancreatic Cancer Clinical Trials in Texas

Find 660 clinical trials for pancreatic cancer near Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 561-580 of 660 trials

Active not recruitingPersonalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal CancerThis phase I trial studies the side effects and best way to give personalized peptide vaccine in patients with pancreatic or colorectal cancer that has spread to other places in…NCT02600949·Houston, Texas CompletedPEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic CancerThis study is designed to compare the treatment effect of PEGPH20 combined with nab-paclitaxel (NAB) and gemcitabine (GEM) \[PAG\] to NAB and GEM \[AG\] in participants with Stage…NCT01839487·Birmingham, Alabama and 50 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesThe primary purpose of this study is to see if Sym024 is safe and tolerable as monotherapy and in combination with Sym021 in patients with solid tumor malignancies.NCT04672434·Grand Rapids, Michigan and 3 others

TerminatedClinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic CancerDetermine the overall response rate (ORR) of bemcentinib plus chemotherapy (nab-paclitaxel/gemcitabine) in patients with metastatic pancreatic adenocarcinoma.NCT03649321·Dallas, Texas

Active not recruitingAcupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing SurgeryThis trial investigates how well acupuncture works for the management of pain after surgery in patients having open colorectal or pancreatic surgery.NCT04560712·Houston, Texas

CompletedChemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic CancerThis pilot clinical trial studies combination chemotherapy and radiation therapy before surgery followed by gemcitabine hydrochloride in treating patients with pancreatic cancer.NCT01821612·La Jolla, California and 13 others

TerminatedCT-95 in Advanced Cancers Associated With Mesothelin ExpressionThis is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor…NCT06756035·Denver, Colorado and 7 others

Active not recruitingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsThis is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1…NCT05945823·Santa Monica, California and 21 others

TerminatedStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsThis study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene…NCT04383210·Birmingham, Alabama and 41 others

CompletedDose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid TumorsThe objectives of this study are to evaluate the safety, tolerability, pharmacokinetics, and biologic effect (FDG PET, preliminary efficacy) of daily oral doses of 2DG with and…NCT00096707·Miami, Florida and 2 others

CompletedA Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell SurfaceThis study is open to adults with advanced solid tumors whose previous cancer treatment was not successful.NCT04752215·Birmingham, Alabama and 13 others

RecruitingA Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.The purpose of this study is to assess the safety, tolerability and efficacy of XER-001 and identify a best dose for future studies.NCT07157033·Duarte, California and 4 others

CompletedQUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerThis is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo plus gemcitabine as first-line treatment of subjects with metastatic pancreatic cancer.NCT00630552·Alhambra, California and 43 others

RecruitingA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsThis is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors.NCT06172478·Duarte, California and 95 others

CompletedGemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryThis randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy regimen with or without radiation…NCT01013649·Mobile, Alabama and 688 others

UnknownPancreatic Cancer Genetic Epidemiology (PACGENE) StudyThe goal of this research study is to investigate the role of genes that may point to a higher risk of developing pancreatic cancer.NCT00526578·Houston, Texas

Active not recruitingA Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.To learn if adding a new medication, IM156, to treatment with gemcitabine and nab-paclitaxel is safe and tolerable.NCT05497778·Houston, Texas

TerminatedA Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsThis study is about TAK-500, given either alone or with pembrolizumab, in adults with select locally advanced or metastatic solid tumors.NCT05070247·Birmingham, Alabama and 11 others

CompletedProspective Study FNB, Is It Time To Abandon Cytological AssessmentEndoscopic Ultrasound (EUS) is a minimally invasive procedure used by gastroenterologists to examine pancreatic masses and lesions.NCT04165018·Houston, Texas and 1 other

TerminatedGemcitabine Pharmacokinetics After Preoperative Chemoradiation TherapyThe goal of this clinical research study is to learn if gemcitabine given during surgery can enter pancreas cancer cells in patients who have already received chemotherapy and…NCT01938716·Houston, Texas

PreviousPage 29 of 33Next

Other Conditions in Texas

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia